176 related articles for article (PubMed ID: 38326754)
21. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma.
Cao J; Wu L; Lei X; Shi K; Shi L; Shi Y
Bioengineered; 2021 Dec; 12(1):673-681. PubMed ID: 33622186
[TBL] [Abstract][Full Text] [Related]
22. Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma.
Zhong Z; Xu M; Tan J
Pathol Oncol Res; 2022; 28():1610670. PubMed ID: 36277962
[No Abstract] [Full Text] [Related]
23. DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma.
Lu Y; Wang S; Chi T; Zhao Y; Guo H; Wang H; Feng L
Sci Rep; 2023 Nov; 13(1):18978. PubMed ID: 37923899
[TBL] [Abstract][Full Text] [Related]
24. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy.
Wu H; Liu TT; Feng YM; Xie XY; Su XN; Qi JN; Zhu Q; Qin CY
J Dig Dis; 2020 Nov; 21(11):650-663. PubMed ID: 32959529
[TBL] [Abstract][Full Text] [Related]
25. Identification of a CD4+ conventional T cells-related lncRNAs signature associated with hepatocellular carcinoma prognosis, therapy, and tumor microenvironment.
Zhu L; Zhang XP; Xu S; Hu MG; Zhao ZM; Zhao GD; Xiao ZH; Liu R
Front Immunol; 2022; 13():1111246. PubMed ID: 36700197
[TBL] [Abstract][Full Text] [Related]
26. Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.
Feng NN; Du XY; Zhang YS; Jiao ZK; Wu XH; Yang BM
Front Endocrinol (Lausanne); 2022; 13():1061091. PubMed ID: 36714595
[TBL] [Abstract][Full Text] [Related]
27. Assessment of prognostic role of a novel 7-lncRNA signature in HCC patients.
Qu J; Tao D; Huang W; Lu L; Fan J; Zhang S; Huang F
Heliyon; 2023 Aug; 9(8):e18493. PubMed ID: 37520979
[TBL] [Abstract][Full Text] [Related]
28. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma.
Xu Q; Wang Y; Huang W
Int Immunopharmacol; 2021 Mar; 92():107333. PubMed ID: 33486322
[TBL] [Abstract][Full Text] [Related]
29. Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer.
Chen E; Yi J; Jiang J; Zou Z; Mo Y; Ren Q; Lin Z; Lu Y; Zhang J; Liu J
BMC Cancer; 2022 Oct; 22(1):1037. PubMed ID: 36195833
[TBL] [Abstract][Full Text] [Related]
30. Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma.
Zhu J; Huang Q; Liu S; Peng X; Xue J; Feng T; Huang W; Chen Z; Lai K; Ji Y; Wang M; Yuan R
Front Immunol; 2022; 13():856186. PubMed ID: 35479067
[TBL] [Abstract][Full Text] [Related]
31. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y
Front Genet; 2021; 12():682082. PubMed ID: 34745200
[No Abstract] [Full Text] [Related]
32. Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods.
Xiong Y; Ouyang Y; Fang K; Sun G; Tu S; Xin W; Wei Y; Xiao W
Comput Math Methods Med; 2022; 2022():4558782. PubMed ID: 35774297
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma.
Chen R; Chen Y; Huang W; Zhao Y; Luo W; Lin J; Wang Z; Yang J
Aging (Albany NY); 2021 Jul; 13(13):17607-17628. PubMed ID: 34237706
[TBL] [Abstract][Full Text] [Related]
34. A New Prognostic Strategy Based on four DNA Repair-Associated lncRNAs for Hepatocellular Carcinoma.
Zeng H; Liu C; Zhou X; Liu L
Comb Chem High Throughput Screen; 2022; 25(5):906-918. PubMed ID: 33653241
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Signature Constructed of Seven Ferroptosis-Related lncRNAs Predicts the Prognosis of HBV-Related HCC.
Wang W; Wang L; Song C; Mu T; Hu J; Feng H
J Gastrointest Cancer; 2024 Mar; 55(1):444-456. PubMed ID: 38006465
[TBL] [Abstract][Full Text] [Related]
36. Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis.
Chen Q; Sun T; Wang G; Zhang M; Zhu Y; Shi X; Ding Z
Dis Markers; 2022; 2022():3265212. PubMed ID: 36452343
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
Wang Y; Song F; Zhang X; Yang C
Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
[TBL] [Abstract][Full Text] [Related]
38. Identification of a Nine Immune-Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma.
Yuan M; Wang Y; Sun Q; Liu S; Xian S; Dai F; Zhang L; Fan Y; Wang F; Yang D; Zheng Y; Deng Z; Tan W; Liu Y; Cheng Y
Biomed Res Int; 2021; 2021():9798231. PubMed ID: 33506049
[TBL] [Abstract][Full Text] [Related]
39. Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma.
Peng YL; Dong YF; Guo LL; Li MY; Liao H; Li RS
PLoS One; 2023; 18(8):e0289552. PubMed ID: 37535570
[TBL] [Abstract][Full Text] [Related]
40. A prognostic signature based on the expression profile of the ferroptosis-related long non-coding RNAs in hepatocellular carcinoma.
Lin X; Yang S
Adv Clin Exp Med; 2022 Oct; 31(10):1099-1109. PubMed ID: 35581934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]